Effects of Cannabidiol on Marijuana-seeking in Humans

Status Completed

Clinical Trial Summary

The purpose of the proposed study is to investigate the effectiveness of cannabidiol for reducing marijuana seeking in non-treatment seeking volunteers. Cannabidiol is a cannabinoid (similar to cannabis, or marijuana) present in marijuana that alters some of the effects of marijuana. Assess the ability of acute smoked CBD pretreatment to reduce marijuana-seeking behavior and increase price-elasticity of marijuana demand.

Clinical Trial Description

Participants will be asked to participate in a total of three choice sessions over two weeks with each session day separated by at least two days. Each session day will last approximately 8 hours. During each study session participants will be asked to smoke a cigarette. Participants will be asked to smoke from a marijuana cigarette. These cigarettes may contain cannabidiol or they may not (placebo). Participants will be asked to answer questions about how the drugs make them feel. Vitals signs (blood pressure, heart rate, and oxygen saturation) will be measured using a non-invasive (external) vitals monitor. Six samples will be taken in each of the three sessions. Blood samples will be obtained via butterfly catheter placed in a vein. Participants will be asked to remain in the laboratory until all marijuana-related subjective and physiological effects have returned to the original levels recorded this morning before they smoked the first marijuana cigarette. ;

Study Design

Related Conditions & MeSH terms

Marijuana Abuse

Clinical Trial Details

NCT number	NCT02777502
Study type	Observational
Source	Wayne State University
Contact
Status	Completed
Phase
Start date	January 1, 2016
Completion date	January 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01539525` - Screening to Augment Referral to Treatment- Project START	Phase 2
Completed	`NCT00158249` - Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals	Phase 2
Completed	`NCT00842985` - Dronabinol Interactions in Humans	N/A
Completed	`NCT00484302` - Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis	N/A
Completed	`NCT00227903` - Therapeutic Substance Abuse Treatment in Pregnancy - 1	Phase 2
Completed	`NCT00227864` - A Brief Marijuana Intervention for Adolescent Women - 1	Phase 3
Completed	`NCT00218478` - Evaluating Responses to Drug-Related Cues Versus Neutral Cues to Understand the Effects of Marijuana Craving - 1	Phase 1
Completed	`NCT00249509` - Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals	Phase 2
Completed	`NCT03717272` - Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects	Phase 2
Completed	`NCT00142961` - Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder	Phase 2
Terminated	`NCT02102230` - CBT-I for Cannabis Use	N/A
Completed	`NCT00580671` - Treatment for Adolescent Marijuana Abuse	N/A
Completed	`NCT00360269` - Atomoxetine Treatment for ADHD and Marijuana Dependence	Phase 2
Completed	`NCT00227916` - Motivational Interviews for Incarcerated Teens - 1	N/A
Completed	`NCT03154567` - Effects of Stress and Drug-cue Exposure (SCM)	Phase 1
Active, not recruiting	`NCT05322941` - Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)	Phase 2
Completed	`NCT02797990` - Conflict Between Maternal Autonomy and Child Health in Substance-use	N/A
Completed	`NCT01762696` - A Real-time, Contextual Intervention Using Mobile Technology to Reduce Marijuana Use in Youth	N/A
Completed	`NCT03154580` - Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users	Phase 1
Completed	`NCT00217971` - Dronabinol Treatment for Marijuana Addiction	Phase 2